These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 33416421)
1. Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Genthon A; Chiarabini T; Baylac P; Valin N; Urbina T; Pacanowski J; Mekinian A; Brissot E; M 'Hammedi-Bouzina F; Lapusan S; Mohty M; Lacombe K; Ingiliz P Leuk Lymphoma; 2021 Jun; 62(6):1502-1505. PubMed ID: 33416421 [No Abstract] [Full Text] [Related]
2. Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report. Schüller H; Klein F; Lübbert M; Prager EP Ann Hematol; 2021 Mar; 100(3):841-842. PubMed ID: 33170342 [No Abstract] [Full Text] [Related]
3. COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria. Pravdic Z; Mitrovic M; Bogdanovic A; Virijevic M; Sabljic N; Pantic N; Vukovic NS Hamostaseologie; 2021 Oct; 41(5):397-399. PubMed ID: 34544179 [TBL] [Abstract][Full Text] [Related]
4. Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders. Araten DJ; Belmont HM; Schaefer-Cutillo J; Iyengar A; Mattoo A; Reddy R Am J Case Rep; 2020 Sep; 21():e927418. PubMed ID: 32917848 [TBL] [Abstract][Full Text] [Related]
5. Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab. Niitsuma-Sugaya I; Kanamori H; Ichikawa S; Fukuhara N; Seike I; Takei K; Baba H; Oshima K; Aoyagi T; Harigae H; Tokuda K Lancet Infect Dis; 2021 May; 21(5):741. PubMed ID: 33894850 [No Abstract] [Full Text] [Related]
6. COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience. Pike A; Muus P; Munir T; Mitchell L; Arnold L; Riley K; Houghton N; Forrest B; Gachev J; Hillmen P; Griffin M Br J Haematol; 2020 Oct; 191(1):e1-e4. PubMed ID: 32945525 [No Abstract] [Full Text] [Related]
11. Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumab in paroxysmal nocturnal haemoglobinuria. Grigg A; Brown M; Szer J Intern Med J; 2010 Nov; 40(11):794-5. PubMed ID: 21108715 [No Abstract] [Full Text] [Related]
12. Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab. Danilov AV; Smith H; Craigo S; Feeney DM; Relias V; Miller KB Leuk Res; 2009 Jun; 33(6):e4-5. PubMed ID: 18952283 [No Abstract] [Full Text] [Related]
13. [Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report]. Horányi D; Várkonyi A; Nagy GR; Bodó I; Masszi T Orv Hetil; 2016 Jun; 157(23):916-8; quiz 919-20. PubMed ID: 27233835 [TBL] [Abstract][Full Text] [Related]
14. [Progress in the management of paroxysmal nocturnal hemoglobinuria by eculizumab]. Nakakuma H Rinsho Ketsueki; 2011 Aug; 52(8):633-44. PubMed ID: 21897069 [No Abstract] [Full Text] [Related]
15. Horse anti-thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient: go or no-go? Alashkar F; Dührsen U; Röth A Eur J Haematol; 2016 Oct; 97(4):403-5. PubMed ID: 26990688 [TBL] [Abstract][Full Text] [Related]
16. Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria. Kawakami T; Nakazawa H; Kurasawa Y; Sakai H; Nishina S; Senoo N; Senoo Y; Ishida F Intern Med; 2018 Jan; 57(1):127-130. PubMed ID: 29021487 [TBL] [Abstract][Full Text] [Related]
17. Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure. Kelly RJ; Hill A; Arnold LM; Khursigara G; Kanagasundaram NS; Hillmen P Leuk Res; 2011 Apr; 35(4):560-2. PubMed ID: 21145109 [No Abstract] [Full Text] [Related]
18. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria. Keating GM; Lyseng-Williamson KA; McKeage K BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448 [TBL] [Abstract][Full Text] [Related]
19. Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab. van Bijnen ST; van Rijn RS; Koljenovic S; te Boekhorst P; de Witte T; Muus P Br J Haematol; 2012 Jun; 157(6):762-3. PubMed ID: 22372429 [No Abstract] [Full Text] [Related]